MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a preventive antibody-based therapy for influenza. The agreement – first ...
MSD is scrapping a £1 billion ($1.35 billion) expansion of its UK operations – including a facility already under construction in London – saying the country does not value innovative medicines. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback